Document Detail

Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
MedLine Citation:
PMID:  8669108     Owner:  NLM     Status:  MEDLINE    
Prostaglandin (PG) E1 administered intravenously has been used for the treatment of primary nonfunction of hepatic allografts and fulminant hepatic failure. It has been proposed that this therapy may improve hepatic blood flow via the vasodilating properties of PGE1. However, PGE1 undergoes extensive metabolic inactivation by the lung and the concentration of PGE1 reaching the liver during intravenous administration has not been determined. Thus, we measured plasma PGE1 concentrations in patients with hepatic dysfunction being treated with PGE1 and in a swine model of PGE1 infusion. We also determined the hemodynamic effects of PGE1 infusion in swine. Blood was sampled from the pulmonary artery, carotid artery, portal vein, and hepatic vein in swine infused with PGE1 (range, 0.67-4.9 microg/kg/hr) demonstrating: (1) a pulmonary extraction ratio of PGE1 of 0.78 +/- 0.12, (2) a splanchnic extraction ratio of PGE1 of 0.54 +/- 0.23, and (3) levels of PGE1 in the systemic circulation of </= 78 pg/ml, even at the highest infusion rates. Despite significant increases in body temperature and pulse rate, hepatic hemodynamics were not affected by the PGE1 infusions in healthy swine. Seven patients receiving intravenous PGE1 for hepatic dysfunction (0.11-1.30 microg/kg/hr) had a pulmonary extraction ratio of 0.69 +/- 0.17. Systemic arterial concentrations of PGE1 were </= 62 pg/ml. These results suggest that due to clearance of PGE2 in the pulmonary and splanchnic circulations, current clinical protocols for intravenous administration of PGE1 are not likely to affect perihepatic hemodynamics.
J A Awas; M C Soteriou; J G Drougas; K A Stokes; L J Roberts; C W Pinson
Related Documents :
8475278 - Upper inferior vena caval anastomotic stenosis in liver transplant recipients: doppler ...
15968898 - Celiac artery aneurysm associated with atherosclerotic common hepatic artery stenosis.
12694098 - Sonographic features of hepatic artery calcification in chronic renal failure.
3207978 - The actions of neuropeptide y and peptide yy on the hepatic arterial and portal vascula...
18255308 - Angiographic results of the radial artery graft patency according to the degree of nati...
23920058 - Residual conduction after pulmonary vein isolation with a circular multielectrode radio...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Transplantation     Volume:  61     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-08-02     Completed Date:  1996-08-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1624-9     Citation Subset:  IM    
Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alprostadil / administration & dosage,  blood*,  pharmacology*
Hemodynamics / drug effects*
Infusions, Intravenous
Middle Aged
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine...
Next Document:  Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochim...